A major milestone in breast cancer research was unveiled at the Beljanski Integrative Cancer Conference, where scientists presented evidence that specific natural compounds can eliminate breast cancer stem cells without harming healthy tissue. These findings, showcased at the conference held April 25 to 27, 2025, in Austin, Texas, spotlighted promising advancements in integrative oncology.

Breast cancer stem cells, a small yet aggressive population within tumors, are known for their resistance to conventional treatments and role in driving recurrence. The new study focuses on a proprietary blend of plant-based compounds including Pao pereira, Rauwolfia vomitoria and green tea extracts, long studied by the Beljanski Foundation for their low toxicity and broad-spectrum anti-cancer effects.

Researchers from the University of Kansas Medical Center reveal these compounds effectively inhibit the proliferation of breast cancer stem cells in animal models. Previous studies funded by the Foundation have shown similar success with pancreatic and ovarian cancers. This latest development may help reduce the high relapse rate among breast cancer patients worldwide.

Sylvie Beljanski, president of the Beljanski Foundation, emphasizes that this breakthrough “represents a transformative step in understanding and addressing the underlying causes of breast cancer relapse.” The findings are scheduled for submission to a peer-reviewed journal, while additional research may soon expand to prostate cancer.